PART I Overview We are a publicly traded biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. Our proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. This advanced enveloped technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis,...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001493152-26-013242 | EDGAR | 145K words |
| 2025-03-31 | 2024-12-31 | 0001641172-25-001810 | EDGAR | — |
| 2024-03-15 | 2023-12-31 | 0001493152-24-010158 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001193125-23-088349 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001193125-22-090215 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001493152-25-022372 | EDGAR | 42K words |
| 2025-08-08 | 2025-06-30 | 0001641172-25-022797 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010317 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044833 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031688 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001493152-24-019305 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001493152-23-041122 | EDGAR | — |
| 2023-08-21 | 2023-06-30 | 0001193125-23-217072 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001193125-23-145095 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001193125-22-282874 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001193125-22-216531 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001193125-22-146662 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0001493152-26-014951 | EDGAR | 1K words |
| 2026-03-27 | 0001493152-26-013236 | EDGAR | — |
| 2026-03-11 | 0001493152-26-009701 | EDGAR | — |
| 2026-02-10 | 0001493152-26-005840 | EDGAR | — |
| 2026-01-29 | 0001493152-26-004089 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022349 | EDGAR | — |
| 2025-11-10 | 0001493152-25-021418 | EDGAR | — |
| 2025-10-31 | 0001493152-25-020390 | EDGAR | — |
| 2025-10-24 | 0001493152-25-019353 | EDGAR | — |
| 2025-09-19 | 0001493152-25-014293 | EDGAR | — |
149 total filings indexed. 122 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001855485 |
| Ticker | CLDI |
| Exchange | NYSE |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.calidibio.com |
| Listed | 2023-09-13 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report